BONAVENTURA, ALDO
 Distribuzione geografica
Continente #
EU - Europa 10.410
Totale 10.410
Nazione #
IT - Italia 10.410
Totale 10.410
Città #
Genova 8.100
Genoa 1.029
Rapallo 1.018
Vado Ligure 237
Bordighera 26
Totale 10.410
Nome #
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. 178
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 171
Alamandine abrogates neutrophil degranulation in atherosclerotic mice 166
C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications 159
Anemia Due to Inflammation in an Anti-Coagulated Patient with Blue Rubber Bleb Nevus Syndrome 149
Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients 146
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 146
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 143
Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality 139
Coronary stenting: A matter of revascularization 133
Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke 133
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis 132
Sepsis by Pasteurella multocida in an Elderly Immunocompetent Patient after a Cat Bite 131
Sofosbuvir/velpatasvir: A promising combination 130
Pre-surgery age-adjusted Charlson Comorbidity Index is associated with worse outcomes in acute cholecystitis 129
The Role of Inflammation in Cardiovascular Outcome 127
Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis 124
Serum PCSK9 levels predict the occurrence of acute coronary syndromes in patients with severe carotid artery stenosis 123
Inflammation and pericarditis: Are neutrophils actors behind the scenes? 119
High serum levels of C-reactive protein (CRP) predict beneficial decrease of visceral fat in obese females after sleeve gastrectomy 119
Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke 118
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function 118
The Role of Adipocytokines in Coronary Atherosclerosis 118
Comment on "Diabetes remission after bariatric surgery is characterized by high glycemic variability and high oxidative stress" 118
The Pathophysiological Role of Neutrophil Extracellular Traps in Inflammatory Diseases 118
Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis 118
Impact of Endocrine Disorders on Vasculature 115
Update on strategies limiting iatrogenic hypoglycemia 114
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 113
Aspirin in primary prevention for patients with diabetes: still a matter of debate 112
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer 112
The need of identifying circulating biomarkers of coronary dysfunction 111
A translational evidence for cholesteryl ester transfer protein (CETP) modulation by glucocorticoids: a time for reflection 111
Comment on "Characterization of circulating leukocytes and correlation of leukocyte subsets with metabolic parameters 1 and 5 years after diabetes diagnosis" 110
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 109
Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery 108
Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: Evaluation with euglycemic clamp and oral fat load 108
Obesity phenotypes and their paradoxical association with cardiovascular diseases 107
Adipocytokine levels in obese and non-obese subjects: An observational study 106
Resistin exerts a beneficial role in atherosclerotic plaque inflammation by inhibiting neutrophil migration 104
The STOP DIABETES study: when prevention works 104
Comment on Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population by Berra et al 103
CCL23 is a promising biomarker of injury in patients with ischemic stroke 102
Reply to “Osteopontin inhibits macrophage cholesterol efflux via NF-κB/ABCA1 pathway” 102
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies 102
The pathophysiological role of cholecystokinin-1 receptor in mouse cholelithogenesis 99
THE EFFECTS OF DIFFERENT DIALYSIS TREATMENTS ON GLYCEMIC EXCURSIONS AND INFLAMMATION IN PATIENTS WITH END-STAGE RENAL DISEASE WITH AND WITHOUT TYPE 2 DIABETES MELLITUS 99
Biophysical aspects and novel treatments of atrial fibrillation 99
Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence 98
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients 97
Steroid-induced hyperglycemia: an underdiagnosed problem or clinical inertia? A narrative review 97
Diabetes and Vascular Disease: is it all about Glycemia? 97
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases 96
Monocyte count at onset predicts post-stroke outcomes during a 90-day follow up 95
Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases 94
Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients 93
Impact of endocrine disorders on blood pressure. 93
Comment on G. Veronese and colleagues. Costs associated with emergency care and hospitalization for severe hypoglycemia 91
T-cells in myocardial infarction: Culprit instigators or mere effectors? 91
Serum levels of osteopontin predict diabetes remission after bariatric surgery 91
Targeting Inflammation in Primary Cardiovascular Prevention 90
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study 90
Reply to "PCSK9: Entering a new era of cardiovascular risk prediction" 90
Alamandine inhibits neutrophil-mediated activities in mouse atherosclerosis. 89
Impact of Red Wine Consumption on Cardiovascular Health 89
Effects of berberine on lipid profile in subjects with low cardiovascular risk 88
Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients 88
Treatment with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors to reduce cardiovascular inflammation and outcomes 87
Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients 87
Cellular recruitment in myocardial ischemia/reperfusion injury 84
Inflammasome Formation in Granulomas in Cardiac Sarcoidosis 84
Low serum C-reactive protein levels predict 90-day mortality in hypoglycaemic patients 82
The NLRP3 inflammasome in acute myocardial infarction 82
Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: A 2-year study evaluation 81
The role of resistin and myeloperoxidase in severe sepsis and septic shock: results from the ALBIOS trial 78
Effects of canrenone in patients with metabolic syndrome 75
Novel findings in neutrophil biology and their impact on cardiovascular disease 75
In-Hospital Initiation of Sacubitril/Valsartan: A New PARADIGM for Acute Decompensated Heart Failure? 74
Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment 74
Antiapolipoprotein A-1 Autoantibody Positivity Is Associated with Threatened Abortion 74
MicroRNA-122 in heart failure with reduced ejection fraction: Epiphenomenon or causal? 71
Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients 71
Comparison of vildagliptin and glimepiride: Effects on glycaemic control, fat tolerance and inflammatory markers in people with Type 2 diabetes 69
Glyco-metabolic profile among type 2 diabetic patients with erectile dysfunction 67
Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists 67
Leptin/adiponectin ratio as a potential predictor of clinical outcome after ischemic stroke. 66
Serum osteopontin as a potential predictor of post-stroke neurological outcome. 66
Troponin elevation does not always mean cardiac ischemia. 65
Neutrophil Extracellular Traps and Cardiovascular Diseases: An Update 65
A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 61
Drugs to Inhibit the NLRP3 Inflammasome: Not Always On Target 61
Early osteopontin levels predict mortality in patients with septic shock 61
PCSK9 is a promising prognostic marker in patients with advanced NSCLC 58
Neutrophil-Related Oxidants Drive Heart and Brain Remodeling After Ischemia/Reperfusion Injury 58
Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19) 57
Enalapril/lercanidipine combination on markers of cardiovascular risk: A randomized study 56
The reduction of matrix metalloproteinase-8 serum levels after bariatric surgery is associated with leptin drop and predicts diabetes remission 55
Effects of Berberis aristata/Silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 54
Serum PCSK9 reduction after ischemic stroke predict worse outcome and higher MACEs occurrence. 53
Serum levels of osteopontin predict atherosclerotic plaque rupture 53
Totale 9.883
Categoria #
all - tutte 36.833
article - articoli 36.083
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 587
Totale 73.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.728 0 0 91 420 348 497 658 367 408 484 314 141
2020/20211.582 126 151 197 213 83 73 63 151 118 174 98 135
2021/20221.476 52 50 90 190 32 138 40 351 149 146 60 178
2022/20231.241 142 89 12 117 178 193 2 106 223 5 150 24
2023/2024803 35 79 22 88 50 124 55 69 48 23 70 140
2024/2025321 123 197 1 0 0 0 0 0 0 0 0 0
Totale 10.974